Hedge fund billionaire John Paulson has been named as the new chairman at Bausch, according to a report by Bloomberg.
Paulson replaces Jospeh Papa who resigned earlier this week. His decision to leave is reported to have no connection to "any dispute or disagreement"
Paulson, the company’s second-largest shareholder, has taken on the position with immediate effect.
Bausch Health is a pharmaceutical and device company with a focus on eye care, gastroenterology and dermatology products.
Yen carry trade risks mount
Hedge funds and other leveraged investors face renewed risks from the yen carry trade as Japan moves further away from decades of…
More
Valour launches first crypto hedge fund using Neuronomics AI strategy
Valour, the digital asset investment products subsidiary of DeFi Technologies, has launched its first hedge fund as it expands beyond…
More
SocGen targets strong prime brokerage growth
Societe Generale is planning to significantly expand its prime brokerage business as part of Chief Executive Officer Slawomir Krupa's…
More
